Target intelligence / Profile preview

Bioactive oligosaccharide

Molecular classification
Carbohydrate, Oligosaccharide
01

Overview

Bioactive oligosaccharides are short-chain carbohydrates, typically consisting of three to ten monosaccharide units, that exert specific biological effects beyond their basic nutritional value. These molecules are found naturally in diverse sources such as human milk (HMOs), plants, and honey, or they can be produced via enzymatic synthesis for use in functional foods and pharmaceuticals (Kunz et al., 2000; Mussig et al., 2021). Their biological roles are vast, including the promotion of beneficial gut microbiota, such as Bifidobacteria, and the inhibition of pathogen adhesion by mimicking the glycan structures found on human intestinal surfaces (Bode, 2012). In clinical contexts, they are investigated for their ability to modulate the immune system, reduce systemic inflammation, and prevent necrotizing enterocolitis or other infectious diseases (Slavin, 2013). However, 'Bioactive oligosaccharides' is a broad chemical classification rather than a specific therapeutic target molecule like a protein or receptor. While specific oligosaccharides like fondaparinux are used as drugs to target proteins like antithrombin, the category as a whole refers to a heterogeneous group of bioactive ligands and dietary fibers.

Other names
Functional oligosaccharidesPrebiotic oligosaccharidesHuman milk oligosaccharidesGlycansComplex carbohydrates
02

Mechanism of action

Bioactive oligosaccharides function as therapeutic ligands or nutritional supplements rather than targets; they act by promoting the growth of beneficial gut bacteria (prebiotic effect), serving as soluble decoy receptors that prevent pathogen binding to host cell surfaces, and modulating immune cell activity through interaction with carbohydrate-binding proteins like lectins.

03

Biological functions

Prebiotic activityImmune system modulationCell-cell recognitionPathogen decoySignal transductionGut microbiome regulation
04

Disease associations

InfectionInflammationGastrointestinal disorderMetabolic diseaseCancerAllergy
05

Safety considerations

Gastrointestinal distress (bloating, flatulence)Osmotic diarrheaHypersensitivity reactionsPotential for cross-reactivity with blood group antigens
06

Interacting drugs

Fondaparinux

5 more in the full profile.

07

Biomarkers

Gut microbiota compositionShort-chain fatty acid (SCFA) levelsC-reactive protein (CRP)Fecal secretory IgA

Beyond the preview

Go deeper on Bioactive oligosaccharide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioactive oligosaccharide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call